BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25961939)

  • 1. A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.
    Moriarity BS; Otto GM; Rahrmann EP; Rathe SK; Wolf NK; Weg MT; Manlove LA; LaRue RS; Temiz NA; Molyneux SD; Choi K; Holly KJ; Sarver AL; Scott MC; Forster CL; Modiano JF; Khanna C; Hewitt SM; Khokha R; Yang Y; Gorlick R; Dyer MA; Largaespada DA
    Nat Genet; 2015 Jun; 47(6):615-24. PubMed ID: 25961939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Sleeping Beauty Screen Highlights Cancer Drivers in Osteosarcoma.
    Cancer Discov; 2015 Jul; 5(7):690. PubMed ID: 25998401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.
    Rahrmann EP; Watson AL; Keng VW; Choi K; Moriarity BS; Beckmann DA; Wolf NK; Sarver A; Collins MH; Moertel CL; Wallace MR; Gel B; Serra E; Ratner N; Largaespada DA
    Nat Genet; 2013 Jul; 45(7):756-66. PubMed ID: 23685747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transposon mutagenesis disentangles osteosarcoma genetic drivers.
    Jones KB
    Nat Genet; 2015 Jun; 47(6):564-5. PubMed ID: 26018893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma.
    Kodama M; Shimura H; Tien JC; Newberg JY; Kodama T; Wei Z; Rangel R; Yoshihara K; Kuruma A; Nakae A; Hashimoto K; Sawada K; Kimura T; Jenkins NA; Copeland NG
    Cancer Res; 2021 Nov; 81(21):5413-5424. PubMed ID: 34475109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative genome analysis of somatic p53 mutant osteosarcomas identifies Ets2-dependent regulation of small nucleolar RNAs by mutant p53 protein.
    Pourebrahim R; Zhang Y; Liu B; Gao R; Xiong S; Lin PP; McArthur MJ; Ostrowski MC; Lozano G
    Genes Dev; 2017 Sep; 31(18):1847-1857. PubMed ID: 29021240
    [No Abstract]   [Full Text] [Related]  

  • 7. A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.
    Mirabello L; Koster R; Moriarity BS; Spector LG; Meltzer PS; Gary J; Machiela MJ; Pankratz N; Panagiotou OA; Largaespada D; Wang Z; Gastier-Foster JM; Gorlick R; Khanna C; de Toledo SR; Petrilli AS; Patiño-Garcia A; Sierrasesúmaga L; Lecanda F; Andrulis IL; Wunder JS; Gokgoz N; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Halai D; Ballinger ML; Thomas DM; Davis S; Barkauskas DA; Marina N; Helman L; Otto GM; Becklin KL; Wolf NK; Weg MT; Tucker M; Wacholder S; Fraumeni JF; Caporaso NE; Boland JF; Hicks BD; Vogt A; Burdett L; Yeager M; Hoover RN; Chanock SJ; Savage SA
    Cancer Discov; 2015 Sep; 5(9):920-31. PubMed ID: 26084801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C; Zhang B; Li YL; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Rahrmann EP; Wolf NK; Otto GM; Heltemes-Harris L; Ramsey LB; Shu J; LaRue RS; Linden MA; Rathe SK; Starr TK; Farrar MA; Moriarity BS; Largaespada DA
    Mol Cancer Res; 2019 Feb; 17(2):567-582. PubMed ID: 30355676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slit-Robo GTPase-Activating Protein 2 as a metastasis suppressor in osteosarcoma.
    Marko TA; Shamsan GA; Edwards EN; Hazelton PE; Rathe SK; Cornax I; Overn PR; Varshney J; Diessner BJ; Moriarity BS; O'Sullivan MG; Odde DJ; Largaespada DA
    Sci Rep; 2016 Dec; 6():39059. PubMed ID: 27966608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.
    de la Rosa J; Weber J; Friedrich MJ; Li Y; Rad L; Ponstingl H; Liang Q; de Quirós SB; Noorani I; Metzakopian E; Strong A; Li MA; Astudillo A; Fernández-García MT; Fernández-García MS; Hoffman GJ; Fuente R; Vassiliou GS; Rad R; López-Otín C; Bradley A; Cadiñanos J
    Nat Genet; 2017 May; 49(5):730-741. PubMed ID: 28319090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coamplification of Myc/Pvt1 and homozygous deletion of Nlrp1 locus are frequent genetics changes in mouse osteosarcoma.
    Rao PH; Zhao S; Zhao YJ; Yu A; Rainusso N; Trucco M; Allen-Rhoades W; Satterfield L; Fuja D; Borra VJ; Man TK; Donehower LA; Yustein JT
    Genes Chromosomes Cancer; 2015 Dec; 54(12):796-808. PubMed ID: 26355645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis.
    Starr TK; Scott PM; Marsh BM; Zhao L; Than BL; O'Sullivan MG; Sarver AL; Dupuy AJ; Largaespada DA; Cormier RT
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5765-70. PubMed ID: 21436051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
    Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
    Elife; 2016 Apr; 5():. PubMed ID: 27070462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleeping Beauty transposon mutagenesis identifies genes that cooperate with mutant Smad4 in gastric cancer development.
    Takeda H; Rust AG; Ward JM; Yew CC; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2057-65. PubMed ID: 27006499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct mechanisms of PTEN inactivation in dogs and humans highlight convergent molecular events that drive cell division in the pathogenesis of osteosarcoma.
    Sarver AL; Mills LJ; Makielski KM; Temiz NA; Wang J; Spector LG; Subramanian S; Modiano JF
    Cancer Genet; 2023 Aug; 276-277():1-11. PubMed ID: 37267683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
    Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
    Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-oriented pathways analysis in pancreatic adenocarcinoma using data from a sleeping beauty transposon mutagenesis screen.
    Ho YY; Starr TK; LaRue RS; Largaespada DA
    BMC Med Genomics; 2016 Apr; 9():16. PubMed ID: 27038937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.
    Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J
    J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
    Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
    Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.